Novosteo Inc. is developing novel therapeutics for the treatment of bone injury and diseases that impact patient mobility and productivity. Our lead compounds are bone-targeted drugs that preferentially accumulate in fracture sites and accelerate new bone synthesis and repair.

Print Friendly, PDF & Email